Literature DB >> 19031668

Pharmacovigilance activities in the United States, European Union and Japan: harmonic convergence or convergent evolution?

Laura B Faden1, Christopher-Paul Milne.   

Abstract

Mesh:

Year:  2008        PMID: 19031668

Source DB:  PubMed          Journal:  Food Drug Law J        ISSN: 1064-590X            Impact factor:   0.619


× No keyword cloud information.
  5 in total

Review 1.  Today's challenges in pharmacovigilance: what can we learn from epoetins?

Authors:  Hans C Ebbers; Aukje K Mantel-Teeuwisse; Ellen H M Moors; Huub Schellekens; Hubert G Leufkens
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

2.  End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.

Authors:  Shamia Hoque; Brian J Chen; Martin W Schoen; Kenneth R Carson; Jesse Keller; Bartlett J Witherspoon; Kevin B Knopf; Y Tony Yang; Benjamin Schooley; Chadi Nabhan; Oliver Sartor; Paul R Yarnold; Paul Ray; Laura Bobolts; William J Hrushesky; Michael Dickson; Charles L Bennett
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

3.  Transnational pharmacogovernance: emergent patterns in the jazz of pharmaceutical policy convergence.

Authors:  Mary Wiktorowicz; Kathy Moscou; Joel Lexchin
Journal:  Global Health       Date:  2018-08-22       Impact factor: 4.185

4.  Don't sell out safety: a call to preserve risk evaluation and mitigation strategies to reduce harm to patients and the public in the U.S.

Authors:  Stacey L Worthy
Journal:  J Pharm Policy Pract       Date:  2016-01-21

5.  Japanese Physicians' Views on Drug Post-Marketing Surveillance.

Authors:  Kazuki Maeda; Rumi Katashima; Keisuke Ishizawa; Hiroaki Yanagawa
Journal:  J Clin Med Res       Date:  2015-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.